Affiliation:
1. Epidemiology and Laboratory Branch, Division of Healthcare Quality Promotion
2. Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia 30333
Abstract
ABSTRACT
We determined the patterns of antimicrobial susceptibility of 65 isolates of
Bacillus anthracis
(50 historical and 15 recent U.S. clinical isolates) to nine antimicrobial agents using the National Committee for Clinical Laboratory Standards (NCCLS) broth microdilution reference method. The results for the 50 historical
B. anthracis
isolates obtained by the broth microdilution method were compared to those generated by the Etest agar gradient diffusion method. One isolate of
B. anthracis
was β-lactamase positive and resistant to penicillin (MIC, 128 μg/ml); a second isolate, which was β-lactamase negative, was borderline penicillin resistant, with the penicillin MICs for the isolate varying from 0.12 to 0.25 μg/ml; and the remainder of the isolates were β-lactamase negative and penicillin susceptible (MICs, ≤0.12 μg/ml). Approximately 78% of the isolates showed reduced susceptibility to ceftriaxone (MICs, ≥16 μg/ml). All
B. anthracis
isolates were susceptible to chloramphenicol (MICs, ≤8 μg/ml), ciprofloxacin (MICs, ≤ 1 μg/ml), clindamycin (MICs, ≤0.5 μg/ml), rifampin (MICs, ≤0.5 μg/ml), tetracycline (MICs, ≤0.06 μg/ml), and vancomycin (MICs, ≤2 μg/ml) by use of NCCLS breakpoints for staphylococci. All 15 recent
B. anthracis
isolates from the United States were susceptible to penicillin, doxycycline, and ciprofloxacin. By use of the susceptibility breakpoint for staphylococci of ≤0.5 μg/ml, 97% of the
B. anthracis
isolates tested would have been categorized as intermediate to erythromycin. No statistically significant difference was found between the results of broth microdilution testing and the results of the Etest method for any of the antimicrobial agents tested; however, the results for penicillin obtained by the Etest were 1 to 9 dilutions lower than those obtained by the broth microdilution method. The differences in the penicillin MICs by the Etest method and the difficulties of reading the Etest results through the glass of a biological safety cabinet may limit the utility of this alternate susceptibility testing method for
B. anthracis
isolates.
Publisher
American Society for Microbiology
Reference28 articles.
1. Centers for Disease Control and Prevention. 2000. Use of anthrax vaccine in the United States. Morb. Mortal. Wkly. Rep.49:1-20.
2. Centers for Disease Control and Prevention. 2000. Surveillance for adverse events associated with anthrax vaccination—U.S. Department of Defense. Morb. Mortal. Wkly. Rep.49:341-345.
3. Centers for Disease Control and Prevention. 2001. Update: investigation of bioterrorism-reported anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. Morb. Mortal. Wkly. Rep.50:909-919.
4. Centers for Disease Control and Prevention. 2001. Notice to readers: update: interim recommendations for antimicrobial prophylaxis for children and breast feeding mothers and treatment of children with anthrax. Morb. Mortal. Wkly. Rep.50:1014-1016.
5. In Vitro Development of Resistance to Ofloxacin and Doxycycline in
Bacillus anthracis
Sterne
Cited by
92 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献